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0.88-1.92) but not in men. The noise exposure level at work was associated with
increased risk of MI in men (OR crude 1.36; 1.03-1.81, OR adjusted 1.43; 1.05-1.96).
Conclusion: Annoyance by environmental noise and the noise exposure level at work is
associated with a moderately increased risk of MI in women and in men, respectively.
Further investigation of the gender related cardiovascular risk of noise burden may eluci-
date the responsible mechanisms and eventually aid in improving preventive strategies of
MI.
1096-73 Internist Use of a Hand Carried Ultrasound Device for 
the Screening of Cardiovascular Disease in the 
Medically Underserved
James N. Kirkpatrick, Jeanne M. DeCara, Roberto M. Lang, Kirk T. Spencer, University of 
Chicago, Chicago, IL
Background. Underserved minority populations have high prevalence of cardiovascular
disease (CVD). Screening for CVD by physical examination is limited by poor sensitivity
and specificity. Reduced access to technology may play a role in delayed detection of
CVD and disparities in cardiac outcomes. Although echocardiography is highly accurate
in detecting CVD, problems of portability and cost of full-featured echo platforms preclude
its use in underserved areas. Hand carried ultrasound (HCU) devices have the potential
to overcome these difficulties. Methods. 153 subjects (mean age 45, range 21-85 years,
54% female, 40% African American, 58% Hispanic) were recruited from a primary care
health clinic in an underserved area to undergo a brief echo examination using an HCU
device (Optigo, Agilent Technologies). Imaging was performed by a general internist with
30 hours of instruction and experience performing 30 exams with the HCU device.
Results. There were 27 clinically significant findings in 19 subjects (12.4%). These find-
ings included significant valvular dysfunction (n=9), regional wall motion abnormalities
(n=7), and ventricular dysfunction (n=8). Abnormal findings were not predicted by patient
age or cardiac risk factors. Patients who presented for a new/acute visit were more likely
to have an abnormality than those who were at the clinic for a return appointment. Con-
clusion. Screening echocardiography performed by an internist with an HCU device
detected clinically significant findings in a clinic that cares for the underserved. Since the
natural history of many cardiac disorders can be modified through treatment, the early
detection of these diseases in underserved populations may improve patient outcomes.
1096-74 Cardiovascular Risk Factors as Correlates of Erectile 
Dysfunction: Results of a Survey in 71,503 Men in Brazil
Edson D. Moreira, Jr., Carmita Abdo, Eric Wroclawski, Joao Fittipaldi, Oswaldo Cruz 
Foundation - Brazilian Ministry of Health, Salvador, Brazil, Sao Paulo University, Sao 
Paulo, Brazil
Background: erectile dysfunction (ED) is now believed to be a vascular problem in its ori-
gin. Several studies have demonstrated an association between coronary artery disease
(CAD) and ED, however the relationship between hypertension, sedentary lifestyle,
smoking and other cardiovascular risk factors with ED remains unclear. Most previous
surveys were small and lacked statistical power to investigate these issues. This analysis
was conducted to assess these potential associations in a large sample of men in Brazil.
Methods: a questionnaire was developed and administered in-person by physicians to a
sample of consecutive male patients attending a routine office consultation. The survey
included 71,503 men aged 18 years or more from 24 states, representing all regions in
Brazil. We queried respondents about the presence of erection difficulties, sedentary life-
style, tobacco use, hypertension, CAD, diabetes, and other medical conditions. The data
have been adjusted for age, and known risk factors for ED by logistic regression. Results:
Overall 31.1% of the men surveyed presented hypertension, 14.1% diabetes, and 7.0%
CAD. Smoking was reported by 44% of the subjects and sedentary lifestyle by 34%.
Some degree of ED was found in 53.5% of the men (20.8% mild, 26.3% moderate and
6.4% complete). In the multivariate analysis, the odds of ED were significantly increased
in men with diabetes (OR=2.4; 95%CI 2.2-2.5), sedentary lifestyle (OR=2.3; 95%CI 2.2-
2.4), CAD (OR=1.5; 95%CI 1.3-1.6), hypertension (OR=1.4; 95%CI 1.3-1.5), and smok-
ing (OR=1.1; 95%CI 1.0-1.2). Conclusions: our data showed that ED is significantly asso-
ciated with the presence of several cardiovascular risk factors. These associations
remained true even after controlling for potential confounding by multivariate analysis.
However, we cannot discern the causal direction of these relationships from cross-sec-
tional data. Indeed, they may simply reflect a common vascular etiology for these condi-
tions. Thus, the presence of cardiovascular risk factors should alert physicians to patients
who are at higher risk for ED, and conversely, erectile difficulties should elicit further
investigation for hidden cardiovascular diseases.
1096-75 Bariatric Surgery Is Effective in Controlling Major Risk 
Factors for Atherosclerosis in Obese Patients With 
Coronary Artery Disease
Sundeep Bhatia, Francisco Lopez-Jimenez, Maria Collazo-Clavell, Michael G. Sarr, 
Virend K. Somers, Mayo Clinic, Rochester, MN
Background: The cornerstone of secondary prevention of coronary artery disease
(CAD) is adequate control of weight, serum glucose, blood pressure and serum lipids.
The efficacy of bariatric surgery on these measures in obese patients with evidence of
CAD is unclear and is the focus of this study.
Methods: Of the 567 consecutive patients who underwent bariatric surgery, 52 (9%) had
CAD based on one or more of the following: history of coronary revascularization (33%,
n=17), significant coronary stenosis by angiogram (48%, n=25), inducible ischemia or
fixed defects on stress imaging (69%, n=36), and/or history of myocardial infarction
(15%, n=8). The efficacy of bariatric surgery was measured by changes in weight and
known cardiovascular risk factors. Goals were defined as a loss of >50% of excess
weight, fasting glucose <100 mg/dL, glycosylated hemoglobin <7% in patients with dia-
betes mellitus, systolic blood pressure (SBP) <130 mmHg, diastolic blood pressure
(DBP) <85 mmHg, and LDL cholesterol <100 mg/dL.
Results: Patients were 51 ± 9 years old and 58% were men. Sixty-four percent had dia-
betes mellitus, 89% had hypertension, and 69% had hyperlipidemia. Improvements in
cardiovascular risk measurements at follow-up (mean 695 days, range 391-896) are
shown below.
Conclusion: Bariatric surgery considerably improves the cardiovascular risk profile in
obese patients with clinical evidence of CAD and should be considered as a therapeutic
option not only for weight loss, but also for risk factor modification.
1096-76 Influence of Serotonin Transporter Gene Polymorphism 
on Depressive Symptoms and Long-Term Outcome 
After Acute Myocardial Infarction
Daisaku Nakatani, Hiroshi Sato, Issei Shiotani, Kunihiro Kinjo, Hiroya Mizuno, Masahiko 
Shimizu, Masatsugu Hori, Osaka University Graduate School of Medicine, Internal 
Medicine and Therapeutics, Suita, Japan
Background: Depression after acute myocardial infarction (AMI) is associated with poor
long-term outcome. How the serotonin transporter gene-linked polymorphic region (5-
HTTLPR) influences either cardiac event or associated with depressive symptoms is
unclear. In the 5-HTTLPR polymorphism, the S allele reduces transcription and therefore
serotonin reuptake, and is linked with psychiatric disease. Methods and Results: To
determine whether the S allele is associated with depressive symptoms and poor out-
come after AMI, we prospectively examined depressive symptoms and long-term cardiac
outcome in 1501 genotyped patients. Depressive symptoms within 3 months after onset
of AMI as assessed by the Self-rating Depression Scale were more frequent in patients
with than without the S allele (48.6% vs. 30.0%, P=0.01). Cardiac events (cardiac death,
need for revascularization, heart failure, reinfarction, arrhythmia, or unstable angina)
were more frequent with than without the S allele (24.3% vs. 12.7%, P=0.02). After
adjustment for other variables, the S allele was independently associated with depressive
symptoms (odds ratio, 2.37; 95% CI, 1.18 to 4.77, P=0.02), but not with increased risk of
poor long-term outcome (hazard ratio, 1.62; 95% CI, 0.80 to 3.26; P=0.18). Conclu-
sions: The S allele of the 5-HTTLPR predicts depressive symptoms and a worse cardiac
outcome. Assessment of 5-HTTLPR genetic variants may be a way to predict risk and
outcome in AMI.
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1115-67 The Medicine, Angioplasty, or Surgery Study (MASS II): 
Quality of Life of Patients With Symptomatic Multivessel 
Coronary Disease-24 Months of Follow-Up
Myrthes Emy Takiuti, Dirceu Carrara, Shirley AB Hiscock, Desiderio Favarato, Neusa H. 
Lopes, Whady A. Hueb, Sergio A. Oliveira, Jose AF Ramires, Heart Institute University of 
Sao Paulo, Sao Paulo-SP, Brazil
Background: although coronary angioplasty (PTCA) and coronary bypass surgery
(CABG) are routinely used, there is no conclusive evidence that these interventional
methods offer greater benefit than medical therapy (MT) alone as far as quality of life
(QOL).
Objective: This study sought to evaluate the QOL of three possible therapeutic strategies
for patients with symptomatic multivessel coronary disease and preserved ventricular
function.
Methods: a total of 7783 elegible patients with multivessel disease were screened in a
single institution and 611 7.8% patients were randomly assigned to undergo CABG, 203
to PTCA 205 and 203 to MT. QOL was evaluated by SF-36 questionnaire by interviews,
in the pre treatment phase at 12 and 24 months of follow up.
Results: although all treatments offered improvement in QOL, such amelioration was
greater in surgical group (table). *p<.0001
Conclusion: In conclusion surgical treatment offers better QOL among patients
with extensive CAD than PCTA or MT. 
The effect of bariatric surgery on modifiable cardiovascular risk factors, *p<0.01, ** p<0.05
Pre-Op Post-Op %Goal Pre-op %Goal Post-op
Weight (kg), n=48 147 ± 36 103 ± 22* -- 63
Body Mass Index (kg/m2), n=48 50 ± 11 36 ± 9* -- --
Fasting Gluose (mg/dL), n=45 149 ± 52 113 ± 31* 16 38**
Glycosylated Hemoglobin (%), n=30 9 ± 3 6 ± 2* 30 70*
SBP (mm Hg), n=43 142 ± 20 133 ± 17* 28 35
DBP (mm Hg), n=43 82 ± 12 73 ± 11* 67 91**
Total Cholesterol (mg/dL), n=36 198 ± 40 142 ± 37* -- --
LDL Cholesterol (mg/dL), n=36 116 ± 31 75 ± 26* 33 89*
Trigylcerides (mg/dL), n=36 198 ± 85 119 ± 52* -- --
HDL Cholesterol (mg/dL), n=36 43 ± 10 44 ± 11 -- --
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1115-68 Predictors of Vascular Complications in Patients 
Undergoing Percutaneous Coronary Intervention and 
Treated With Vascular Closure Devices
Raj Goswami, John G. McGinnity, Arthur L. Riba, Cecelia K. Montoye, Dean E. Smith, 
Julius Gardin, Michael J. O'Donnell, Anthony C. DeFranco, David Share, Mauro 
Moscucci, For The Blue Cross Blue Shield of Michigan Cardiovascular Consortium 
(BMC2), University of Michigan, Ann Arbor, MI
Objective. The objective of our study was to identify clinical predictors of vascular com-
plications in patients undergoing contemporary percutaneous coronary interventions and
treated with vascular closure devices, VCDs (Vasoseal, Angioseal, Perclose, or others).
Methods. Clinical, procedural and outcome data on 27,202 consecutive PCIs were pro-
spectively collected between April 2001 and May 2003 in a consortium of 16 hospitals in
Michigan. Independent predictors of vascular complications (VC) were identified using
multivariate logistic regression analysis.
Results. 6270 patients received a vascular closure device. Vasoseal was used in 2.7%,
Angioseal in 41.9%, Perclose in 54.7% and other devices in 0.7%. The overall vascular
complication rate in this group was 3.3%. There was a non-significant trend toward an
increased incidence of VC in patients treated with Vasoseal (4.38%) when compared
with patients treated with Angioseal (2.98%) or Perclose (3.46%). Of 28 clinical and treat-
ment variables including type of vascular closure device, multivariate analysis identified
advanced age, female sex, acute myocardial infarction, cardiac arrest, cardiogenic shock
and glycoprotein IIb/IIIa receptor blocker use as independent predictors of VC (all
p<0.05).
Conclusions. Baseline clinical characteristics identify patients at increased risk of vas-
cular complications following use of VCD. The occurrence of vascular complications in
these patients appears to be independent of the type of VCD.
1115-69 Lower Hematocrit Is Associated With Worse Health 
Status in Patients With Heart Failure
Avinash Khanna, Mikhail Kosoborod, Philip Jones, Harlan M. Krumholz, John A. Spertus, 
Mid America Heart Institute and University of Missouri at Kansas City, Kansas City, MO, 
Yale University, New Haven, CT
Background: Anemia is a potentially modifiable comorbid condition in patients with heart
failure (HF). Its effect on health status has not been well defined. We tested the hypothe-
sis that lower hematocrit levels in patients with post-Myocardial Infarction (MI) HF are
associated with worse quality of life as measured by the Kansas City Cardiomyopathy
Questionnaire (KCCQ).
Methods: The EPHESUS trial enrolled 6632 patients with post-MI HF, of which 1578 par-
ticipated in the quality of life substudy. 3-month KCCQ scores were compared across the
following ranges of hematocrit: <0.33, 0.33-0.35, 0.36-0.38, 0.39-0.41, 0.42-0.44 and
>0.45. This time was selected to reflect a chronic HF state following patients’ MI.
Results: Compared with non-anemic patients, anemic patients (hematocrit <0.39) were
more likely to be female (46% vs 20%, p<0.001), older (68±24 vs 62±23, p<0.0001), dia-
betic (34% vs 23%, p<0.0001) and to have a higher serum creatinine (1.3 ± 1.0 vs 1.1±
0.6, p<0.001). Lower hematocrits were associated with worse (lower) KCCQ scores.
After adjusting for baseline demographic and clinical differences, a highly significant rela-
tionship between hematocrit and KCCQ summary scores was observed (Adjusted
Means shown in Figure, p<0.0001).
Conclusions: Lower hematocrits are associated with worse quality of life in HF patients,
even after controlling for a range of potentially confounding factors. Further investigation
of the health status benefits from correcting anemia in HF patients appears warranted. 
1115-70 Effect of Obesity on Long-Term Survival Following 
Percutaneous Coronary Intervention
Kenneth C. Wen, Timothy A. Sanborn, Warren Sherman, David L. Brown, Beth Israel 
Medical Center, New York, NY
Background: Obesity is a powerful risk factor for the development of coronary artery dis-
ease. Paradoxically, recent studies have suggested that obesity actually protects against
mortality following percutaneous coronary intervention (PCI).We sought to determine the
impact of obesity on long-term survival following PCI using a contemporary database.
Methods: The study population consisted of 4284 consecutive patients undergoing PCI
from January 1, 1998 to October 1, 1999 at 3 hospitals in New York City. Patients were
then divided into two groups, obese patients with body mass index (BMI) > 30 (n=1,410)
and non-obese patients with BMI < 30 (n=2,874). Primary endpoint was all-cause mortal-
ity following the index PCI. Mean follow-up was 3 years. Results: Obese patients were
younger (60 vs. 65 years, P<0.001) and more frequently female (36% vs. 29%, P<0.001).
Mean BMI was 34.7 in the obese patients and 25.6 in the non-obese patients (P<0.001).
Hypertension (74% vs. 68%, P<0.001) and diabetes (33% vs. 24%, P<0.001) were more
common in obese patients while peripheral vascular disease (6.1% vs. 8.7%, P<0.001)
and prior bypass surgery (14% vs. 19%, P<0.001) were less common. Presentation with
myocardial infarction (9.4% vs. 11%, P=NS) and unstable angina (41% vs. 43%, P=NS)
did not differ between obese and non-obese patients. Single-vessel coronary disease
was more common in obese patients (53% vs. 46%, P<0.001) and mean ejection frac-
tions were slightly greater (51% vs. 50%, P=0.04). Stent use did not differ between
groups. Angiographic success was slightly reduced in obese patients (96% vs. 97%,
P=0.06). In-hospital major adverse cardiac events did not differ between obese and non-
obese patients. Out-of-hospital death was 7.2% for obese patients and 10.3% in the non-
obese (P=0.001). After adjustment for differences in baseline characteristics, obesity was
found not to be associated with an increased hazard of long-term mortality (Hazard
Ratio, 0.992, 95% Confidence Interval, 0.784 – 1.254, P=0.945). Conclusion: Obesity
does not appear to protect patients from long-term mortality following PCI. However, nei-
ther does it increase the hazard of 3-year mortality after adjustment for other co-morbidi-
ties.
1115-71 Depression Is Strongly Associated With Worse Health 
Status in Patients With Myocardial Infarction 
Complicated by Heart Failure: Data From the EPHESUS 
Trial
John S. Rumsfeld, Mary A. Whooley, Philip Jones, Mark D. Sullivan, Pamela N. Peterson, 
William S. Weintraub, Bertram Pitt, John A. Spertus, Denver VA Medical Center, Denver, 
CO, University of Missouri-Kansas City, Kansas City, MO
Background: We evaluated the relationship between depression and health status in
patients with acute MI complicated by heart failure.
Methods: Patients in the EPHESUS trail (NEJM, 2003) completed a Medical Outcomes
Study-Depression (MOS-D) questionnaire at baseline and Kansas City Cardiomyopathy
Questionnaire (KCCQ) at baseline,1,3,6, and 12 months. The KCCQ measures heart-
failure health status including symptoms, physical function, and quality of life. The KCCQ
summary score has range 0-100; higher scores = better health status; 5 points = clini-
cally important score difference. We used repeated measures and multivariable regres-
sion to evaluate the association between depressive symptoms (MOS-D score > 0.06)
and KCCQ summary scores.
Results: 93/423 patients (22%) had significant depressive symptoms. Depressed
patients had markedly lower KCCQ scores during follow-up (Figure). After risk adjust-
ment, depression remained significantly associated with worse baseline (p<0.001) and
12-month (p<0.001) KCCQ scores - on average, depressed patients had 8.8 point lower
KCCQ scores at baseline and 13.4 point lower KCCQ scores at 12-months. Depressive
symptoms were the strongest predictor of health status in the multivariable models.
Conclusion: In patients with AMI complicated by heart failure, depressive symptoms are
1
Treatment Angioplasty Clinica
l
Surgery p
Period pre 12m 24m pre 12m 24m pre 12m 24m
Physical Functioning 59 72,8 72,44 50 66,2 62,50 47 73,5 73,69 0,002
Role Physical 34 52,6 51,13 23 39,8 38,49 21 48,2 50,19 0,018
General Health 65 63,8 66,09 63 60,8 62,40 63 64,4 68,19 0,018
Mental Health 66 74,6 42,59 63 70,4 42,47 64 74 41,14 NS
Vitality 64 72,2 46,13 56 61,6 41,94 56 73,8 45,27 0,02
Role Emotional 52 67,1 69,92 50 64,9 64,91 46 68,9 68,72 NS
Social Functioning 58 70 86,28 57 62,7 80,35 53 66,9 87,60 0,02
Bodly Pain 63 75,4 70,50 62 70,1 67,30 57 76,8 73,55 NS
